Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. DEFA14A Proxy Proxy Materials
  2. DEF 14A Proxy Proxy Statement
  3. 8-K Event Executive or director change
  4. 8-K Event Executive or director change
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. SC TO-I Deal Tender Offer Statement by Issuer
  8. 8-K Event Acquisition or sale completed · Regulation FD disclosure
  9. 8-K Event Material agreement · Other events
  10. 10-K Report Annual Report
  11. 8-K Event Shareholder vote results
  12. 8-K Event Results of operations
  13. DEFA14A Proxy Proxy Materials
  14. 8-K Event Other events
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. DEFA14A Proxy Proxy Materials
  18. DEFM14A Deal DEFM14A
  19. 4 Shares withheld for taxes Chief Financial Officer gave up 1,711 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Commercial Officer gave up 4,858 shares (to pay taxes)

Page 5 of 47 · 923 filings